MK-8776 (SCH 900776)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for MK-8776 (SCH 900776), covering 2017-06-20 to 2017-06-20. Get the full timeline:
Most recent: Clinical Trial Update: A Dose-escalation Study of MK-8776 (SCH 900776) With and Without Gemcitabine in Participants With Solid Tumors or Lymphoma (MK-8776-002/P05248) [Phase 1]